MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5551/jat.63076

Медицинская библиотека · Journal of atherosclerosis and thrombosis · 2021

Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study.

Lin Jia-Ling, Chen Po-Sheng, Lin Hui-Wen, Tsai Liang-Miin, Lin Sheng-Hsiang, Li Yi-Heng

СтатьяПеревод пока не подготовлен

Аннотация

AIM: The safety concern of statins is still a major issue for Asians. The aim of this study is to compare the risk of statin-associated adverse events among potent statins.

METHODS

We included patients from the Taiwan National Health Insurance Research Database who had been treated with atorvastatin, rosuvastatin, or pitavastatin and were without diabetes at baseline. They were classified into three groups: usual-dose statin (atorvastatin 10 mg/d or rosuvastatin 5-10 mg/d), high-dose statin (atorvastatin 20-40 mg/d and rosuvastatin 20 mg/d), and pitavastatin (2-4 mg/d). The primary endpoint is a composite of safety events, including hepatitis, myopathy, and new-onset diabetes mellitus (NODM). We matched age, sex, and year of recruitment among the three groups (n=50,935 in each group) and then used the multivariate Cox proportional hazards model to evaluate the relation between the safety endpoint and different statin groups.

RESULTS

After a mean follow-up of 3.08±0.83 years, the safety events occurred in 9.84% in the pitavastatin group, 10.88% in the usual-dose statin group, and 10.49% in high-dose statin group. The multivariate Cox proportional hazards model indicated that usual-dose statin and high-dose statin were associated with a higher risk of the composite safety events compared with pitavastatin (adjusted hazard ratio [aHR]: 1.12, 95% confidence interval [CI]: 1.08-1.17 for usual-dose statin and aHR: 1.06, 95% CI: 1.02-1.10 for high-dose statin). The risks of hepatitis requiring hospitalization and NODM were especially lower in pitavastatin group.

CONCLUSIONS

Compared with atorvastatin and rosuvastatin, pitavastatin might be associated with a lower risk of safety events in Asians.

Для цитирования: Lin Jia-Ling, Chen Po-Sheng, Lin Hui-Wen, Tsai Liang-Miin, Lin Sheng-Hsiang, Li Yi-Heng. Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study.. Journal of atherosclerosis and thrombosis. 2021. DOI: 10.5551/jat.63076.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.